Skip to main content
. 2022 Jun 24;17(6):e0269386. doi: 10.1371/journal.pone.0269386

Table 5. COVID-19 myocarditis gene-targeted drugs.

Term P-value Combined Score Genes
etoposide MCF7 DOWN 4.36E-10 19544.37 CDC20; UBE2C; KIF2C; KIF20A
methotrexate MCF7 DOWN 6.07E-10 17637.87 CDC20; UBE2C; KIF2C; KIF20A
LUCANTHONE CTD 00006227 7.78E-10 9976.195 CDC20; CDK1; PBK; KIF2C; KIF20A
troglitazone CTD 00002415 1.16E-09 2388335 CDC20; UBE2C; CDK1; PBK; KIF2C; KIF20A
ciclopirox MCF7 DOWN 1.72E-09 12770.53 CDC20; UBE2C; KIF2C; KIF20A
5109870 MCF7 DOWN 1.82E-09 12532.66 CDC20; UBE2C; KIF2C; KIF20A
thalidomide CTD 00006858 3.51E-08 4975.73 CDC20; UBE2C; CDK1; KIF2C
genistein CTD 00007324 5.37E-08 1885048 CDC20; UBE2C; CDK1; PBK; KIF2C; KIF20A
dmnq CTD 00002569 5.41E-08 4339.482 CDC20; UBE2C; PBK; KIF2C
testosterone CTD 00006844 5.81E-08 1874705 CDC20; UBE2C; CDK1; PBK; KIF2C; KIF20A